| 2025-12-01 |
详情>>
内部人交易：
PACKER RICHARD A共交易2笔
|
| 2025-11-05 |
详情>>
股本变动：
变动后总股本15194.11万股
|
| 2025-11-05 |
详情>>
业绩披露：
2025年三季报(累计)每股收益-0.25美元,归母净利润-3740万美元,同比去年增长-137.63%
|
| 2025-11-03 |
财报披露：
美东时间 2025-11-03 盘前发布财报
|
| 2025-08-06 |
详情>>
业绩披露：
2025年中报每股收益0.16美元,归母净利润2500.00万美元,同比去年增长-57.26%
|
| 2025-05-07 |
详情>>
业绩披露：
2025年一季报每股收益0.11美元,归母净利润1740.00万美元,同比去年增长-65.82%
|
| 2025-04-11 |
股东大会：
将于2025-05-29召开股东大会
会议内容 ▼▲
- 1.To elect the nominees for director named in the accompanying Proxy Statement to hold office until the 2028 Annual Meeting of Stockholders.
2.To hold an advisory vote to approve the 2024 compensation of our named executive officers.
3.To ratify the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for fiscal year 2025.
4.To approve the adoption of the Bruker Corporation 2026 Incentive Compensation Plan.
5.To transact such other business as may properly come before the meeting or any adjournment or postponement thereof.
|
| 2025-03-03 |
详情>>
业绩披露：
2024年年报每股收益0.76美元,归母净利润1.13亿美元,同比去年增长-73.53%
|
| 2025-03-03 |
详情>>
业绩披露：
2022年年报每股收益2.00美元,归母净利润2.97亿美元,同比去年增长7.04%
|
| 2024-11-07 |
详情>>
业绩披露：
2024年三季报(累计)每股收益0.67美元,归母净利润9940.00万美元,同比去年增长-55.16%
|
| 2024-08-09 |
详情>>
业绩披露：
2023年中报每股收益0.91美元,归母净利润1.34亿美元,同比去年增长20.25%
|
| 2024-08-09 |
详情>>
业绩披露：
2024年中报每股收益0.40美元,归母净利润5850.00万美元,同比去年增长-56.21%
|
| 2024-05-10 |
详情>>
业绩披露：
2024年一季报每股收益0.35美元,归母净利润5090.00万美元,同比去年增长-33.46%
|
| 2024-04-19 |
股东大会：
将于2024-05-30召开股东大会
会议内容 ▼▲
- 1.To elect the nominees for director named in the accompanying Proxy Statement to hold office until the 2027 Annual Meeting of Stockholders.
2.To hold an advisory vote to approve the 2023 compensation of our named executive officers.
3.To ratify the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for fiscal year 2024.
4.To transact such other business as may properly come before the meeting or any adjournment or postponement thereof.
|
| 2024-02-29 |
详情>>
业绩披露：
2023年年报每股收益2.92美元,归母净利润4.27亿美元,同比去年增长44.03%
|
| 2023-11-09 |
详情>>
业绩披露：
2023年三季报(累计)每股收益1.51美元,归母净利润2.22亿美元,同比去年增长11.30%
|
| 2023-04-28 |
股东大会：
将于2023-06-07召开股东大会
会议内容 ▼▲
- 1.To elect the nominees for director named in the accompanying Proxy Statement to hold office until the 2026 Annual Meeting of Stockholders.
2.To hold an advisory vote to approve the 2022 compensation of our named executive officers.
3.To hold an advisory vote on the frequency of future advisory votes on named executive officer compensation.
4.To ratify the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for fiscal year 2023.
5.To transact such other business as may properly come before the meeting or any adjournment or postponement thereof.
|
| 2022-04-22 |
股东大会：
将于2022-06-01召开股东大会
会议内容 ▼▲
- 1.To elect the nominees for director named in the accompanying Proxy Statement to hold office until the 2025 Annual Meeting of Stockholders.
2.To hold an advisory vote to approve the compensation paid to our named executive officers.
3.To ratify the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for fiscal year 2022.
4.To approve the Bruker Corporation 2022 Employee Stock Purchase Plan.
5.To transact such other business as may properly come before the meeting or any adjournment or postponement thereof.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-04-20 |
股东大会：
将于2021-06-04召开股东大会
会议内容 ▼▲
- 1.To elect the nominees for director named in the accompanying Proxy Statement to hold office until the 2024 Annual Meeting of Stockholders.
2.To hold an advisory vote to approve compensation paid to our named executive officers.
3.To ratify the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for fiscal year 2021.
4.To transact such other business as may properly come before the meeting or any adjournment or postponement thereof.
|
| 2020-04-22 |
股东大会：
将于2020-05-21召开股东大会
会议内容 ▼▲
- 1.To elect the Class II nominees for director named in the accompanying proxy statement to hold office until the 2023 Annual Meeting of Stockholders.
2.To hold an advisory vote to approve compensation paid to our named executive officers.
3.To ratify the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for fiscal year 2020.
4.To transact such other business as may properly come before the meeting or any adjournment or postponement thereof.
|
| 2020-02-20 |
除权日：
美东时间 2020-03-06 每股派息0.04美元
|
| 2019-11-14 |
除权日：
美东时间 2019-11-29 每股派息0.04美元
|
| 2019-08-12 |
除权日：
美东时间 2019-08-30 每股派息0.04美元
|
| 2019-05-10 |
除权日：
美东时间 2019-05-31 每股派息0.04美元
|
| 2019-04-17 |
股东大会：
将于2019-05-20召开股东大会
会议内容 ▼▲
- 1.To elect the Class I nominees for director named in the accompanying proxy statement to hold office until the 2022 Annual Meeting of Stockholders and the Class III nominee for director named in the accompanying proxy statement to hold office until the 2021 Annual Meeting of Stockholders.
2.To hold an advisory vote to approve compensation paid to our named executive officers.
3.To ratify the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for fiscal year 2019.
4.To transact such other business as may properly come before the meeting or any adjournment or postponement thereof.
|
| 2019-02-15 |
除权日：
美东时间 2019-03-04 每股派息0.04美元
|
| 2018-11-09 |
除权日：
美东时间 2018-11-30 每股派息0.04美元
|
| 2018-08-13 |
除权日：
美东时间 2018-08-31 每股派息0.04美元
|
| 2018-05-14 |
除权日：
美东时间 2018-06-01 每股派息0.04美元
|
| 2018-04-17 |
股东大会：
将于2018-05-21召开股东大会
会议内容 ▼▲
- 1.To elect the Class III nominees for director named in the accompanying proxy statement to hold office until the 2021 Annual Meeting of Stockholders.
2.To hold an advisory vote to approve compensation paid to our named executive officers.
3.To ratify the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for fiscal year 2018.
4.To transact such other business as may properly come before the meeting or any adjournment or postponement thereof.
|
| 2018-02-20 |
除权日：
美东时间 2018-03-05 每股派息0.04美元
|
| 2017-11-13 |
除权日：
美东时间 2017-12-01 每股派息0.04美元
|
| 2017-08-14 |
除权日：
美东时间 2017-08-31 每股派息0.04美元
|
| 2017-04-30 |
除权日：
美东时间 2017-06-01 每股派息0.04美元
|
| 2017-04-17 |
股东大会：
将于2017-05-22召开股东大会
会议内容 ▼▲
- 1.To elect the Class II nominees for director named in the accompanying proxy statement to hold office until the 2020 Annual Meeting of Stockholders and the Class III nominee for director named in the accompanying proxy statement to hold office until the 2018 Annual Meeting of Stockholders.
2.To hold an advisory vote to approve compensation paid to our named executive officers.
3.To hold an advisory vote regarding the frequency of future advisory votes on executive compensation.
4.To ratify the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for fiscal year 2017.
5.To transact such other business as may properly come before the meeting or any adjournment or postponement thereof.
|
| 2017-02-21 |
除权日：
美东时间 2017-03-06 每股派息0.04美元
|
| 2016-11-14 |
除权日：
美东时间 2016-12-01 每股派息0.04美元
|
| 2016-08-09 |
除权日：
美东时间 2016-09-01 每股派息0.04美元
|
| 2016-05-17 |
除权日：
美东时间 2016-06-02 每股派息0.04美元
|
| 2016-04-22 |
股东大会：
将于2016-05-20召开股东大会
会议内容 ▼▲
- 1.To elect the Class I nominees for director named in the accompanying proxy statement to hold office until the 2019 Annual Meeting of Stockholders and the Class II nominee for director named in the accompanying proxy statement to hold office until the 2017 Annual Meeting of Stockholders.
2.To approve the adoption of the Bruker Corporation 2016 Incentive Compensation Plan.
3.To transact such other business as may properly come before the meeting or any adjournment or postponement thereof.
|
| 2016-02-22 |
除权日：
美东时间 2016-03-02 每股派息0.04美元
|